This is an AMP page which is for mobile devices.
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
home / articles / AMAM - Cancer Focused Ambrx Biopharma Stock Trading Lower Today - Here's Why | Benzinga
Ambrx Biopharma Inc (NASDAQ: AMAM) announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic castration-resistant prostate cancer (mCRPC) were made available as part of the 2023 European Society of Medical Oncology Congress 2023 meeting.
APEX-01 opened for enrollment in ...
| Company Name: | Ambrx Biopharma Inc. American Depositary Shares (each representing seven) |
| Stock Symbol: | AMAM |
| Market: | NYSE |
| Website: | ambrx.com |
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.